Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zymeworks Inc. (NYSE:ZYME – Get Free Report) shares hit a new 52-week high on Tuesday . The stock traded as high as $12.71 and last traded at $12.52, with a volume of 90247 shares changing hands. The stock had previously closed at $12.37. Zymeworks Stock Performance The firm has a fifty day simple moving average […]
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the sta
InMed Pharmaceuticals Inc. announced on February 8, 2024, the Board of Directors of the company appointed Ms. N. Netta Neeta Jagpal to serve, effective as of February 20, 2024 , as Corporate...
VANCOUVER, British Columbia, Feb. 08, 2024 -- Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard...
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The